7 Heart Attack Clinical Trials in Anchorage, AK (2026)

Q: How do I join a clinical trial in Anchorage?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Anchorage research site will contact you.

Recruiting Heart Attack Studies in Anchorage

NCT00271180Recruiting

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzi...

Anchorage, AK20,000 participantsMedtronic

View Study Details

NCT04726241Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from pati...

Anchorage, AKPHASE1960 participantsPedAL BCU, LLC

View Study Details

NCT04546399Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come ...

Anchorage, AKPHASE2461 participantsNational Cancer Institute (NCI)

View Study Details

NCT04269902Recruiting

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic ...

Anchorage, AKPHASE3247 participantsNational Cancer Institute (NCI)

View Study Details

NCT06317662Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

This phase II trial tests the addition of venetoclax and/or blinatumomab to usual chemotherapy for treating infants with newly diagnosed acute lymphoblastic leukemia (ALL) with a KMT2A gene rearrangem...

Anchorage, AKPHASE2153 participantsNational Cancer Institute (NCI)

View Study Details

NCT03739814Recruiting

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

This phase II trial studies how well inotuzumab ozogamicin and blinatumomab with or without ponatinib work in treating patients with CD22-positive B-lineage acute lymphoblastic leukemia that is newly ...

Anchorage, AKPHASE284 participantsNational Cancer Institute (NCI)

View Study Details

NCT02981628Recruiting

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with B-lymphoblastic lymphoma or CD22 positive B acute lymphoblastic leukemia that has come back (relapsed...

Anchorage, AKPHASE280 participantsChildren's Oncology Group

View Study Details

About Heart Attack Clinical Trials in Anchorage

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 7 heart attack clinical trials recruiting participants in Anchorage, AK. These studies are seeking a combined 21,985 participants. Research is being sponsored by Medtronic, PedAL BCU, LLC, National Cancer Institute (NCI) and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Anchorage — FAQ

Are there heart attack clinical trials in Anchorage?

Yes, there are 7 heart attack clinical trials currently recruiting in Anchorage, AK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Anchorage?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Anchorage research site will contact you about next steps.

Are clinical trials in Anchorage free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Anchorage studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 7 active trials in Anchorage are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated July 19, 2026 from ClinicalTrials.gov